[1] VUPPALANCHI R,LIANGPUNSAKUL S,CHALASANI N. Etiology of new-onset jaundice:How often is it caused by idiosyncratic drug-induced liver injury in the United States?[J].Am J Gastroenterol,2007,102(3):558-562; quiz 693.
|
[2] CHAYANUPATKUL M,SCHIANO TD. Acute liver failure secondary to drug-induced liver injury[J]. Clin Liver Dis,2020,24(1):75-87.
|
[3] JAESCHKE H,MCGILL MR,RAMACHANDRAN A. Oxidant stress,mitochondria,and cell death mechanisms in drug-induced liver injury:Lessons learned from acetaminophen hepatotoxicity[J]. Drug Metab Rev,2012,44(1):88-106.
|
[4] ZHANG TT,XU XL,JIANG MH,et al. Hepatoprotective function of Penthorum Chinense Pursh[J]. Food Funct,2013,4(11):1581-1585.
|
[5] ZHANG X,MENG CW,HE YC,et al. Study on Flavonoids of Penthorum Chinense[J]. Chin Tradit Herb Drug,2017,48(1):31-35.(in Chinese)张潇,蒙春旺,何亚聪,等.赶黄草黄酮类化学成分研究[J].中草药,2017,48(1):31-35.
|
[6] ZHOU F,WANG A,LI D,et al. Pinocembrin from Penthorum chinense Pursh suppresses hepatic stellate cells activation through a unified SIRT3-TGF-β-Smad signaling pathway[J]. Toxicol Appl Pharmacol,2018,341:38-50.
|
[7] ZHANG HW,ZHANG L. Research progress on pinocembrin:Potential therapeutic applications and action mechanisms[J]. Acta Neuropharmacologica,2016,6(5):45-52.(in Chinese)张海威,张力.乔松素临床应用和作用机制的研究进展[J].神经药理学报,2016,6(5):45-52.
|
[8] QI J,ZHOU Z,LIM CW,et al. Amlexanox ameliorates acetaminophen-induced acute liver injury by reducing oxidative stress in mice[J]. Toxicol Appl Pharmacol,2019,385:114767.
|
[9] YOON E,BABAR A,CHOUDHARY M,et al. Acetaminophen-induced hepatotoxicity:A comprehensive update[J]. J Clin Transl Hepatol,2016,4(2):131-142.
|
[10] YAN M,HUO Y,YIN S,et al. Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions[J]. Redox Biol,2018,17:274-283.
|
[11] JIANG H,BAI XF. Research advances in acute liver failure[J]. J Clin Hepatol,2018,34(9):1824-1831.(in Chinese)姜泓,白雪帆.急性肝衰竭研究进展[J].临床肝胆病杂志,2018,34(9):1824-1831.
|
[12] YU PF,WU Q,DUAN ZP,et al. Research advances in the mechanism of drug-induced liver injury due to paracetamol[J]. J Clin Hepatol,2019,35(9):2108-2112.(in Chinese)余朋飞,吴桥,段钟平,等.对乙酰氨基酚致药物性肝损伤的机制研究进展[J].临床肝胆病杂志,2019,35(9):2108-2112.
|
[13] KON K,KIM JS,JAESCHKE H,et al. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes[J]. Hepatology,2004,40(5):1170-1179.
|
[14] SAAD MA,ABDEL SALAM RM,KENAWY SA,et al. Pinocembrin attenuates hippocampal inflammation,oxidative perturbations and apoptosis in a rat model of global cerebral ischemia reperfusion[J]. Pharmacol Rep,2015,67(1):115-122.
|
[15] PROMSAN S,JAIKUMKAO K,PONGCHAIDECHA A,et al.Pinocembrin attenuates gentamicin-induced nephrotoxicity in rats[J]. Can J Physiol Pharmacol,2016,94(8):808-818.
|
[16] FAN L,XIE XX,CHEN L,et al. Protective effects of three Penthorum Chinense extracts on endotoxin-induced liver injury in mice[J]. Chin Tradit Patent Med,2019,41(2):291-297.(in Chinese)范玲,谢星星,陈立,等.赶黄草3种提取物对小鼠内毒素性肝损伤的保护作用[J].中成药,2019,41(2):291-297.
|
[17] PUNVITTAYAGUL C,WONGPOOMCHAI R,TAYA S,et al.Effect of pinocembrin isolated from Boesenbergia pandurata on xenobiotic-metabolizing enzymes in rat liver[J]. Drug Metab Lett,2011,5(1):1-5.
|
1. | 路燕,陈明月,郑秀良,雷宇. 185例药物性肝损伤患者的临床特征分析. 安徽医学. 2022(03): 308-313 . ![]() | |
2. | 赵临潇,左博云,李静亚,于东升. 妊娠期肝内胆汁淤积症孕妇胎盘ABCB4基因表达与妊娠结局的关系. 海南医学. 2022(11): 1424-1427 . ![]() | |
3. | 张慧芳,王高莹,邹萍,王晶,董蕊锐,张婷,孟西娜. 妊娠期肝内胆汁淤积症血清甘胆酸水平与妊娠结局的关系. 中国临床研究. 2022(06): 793-796 . ![]() | |
4. | 林洪萍,黄晋萍,黄淑兰,卢君,黎春,杨佳柳. 中药外洗在妊娠期肝内胆汁淤积症诱发皮肤瘙痒患者中的应用. 中国医学创新. 2022(19): 96-99 . ![]() | |
5. | 李媛,郑泽玉,田阗,邬洪明,田嫣然,李茂. 妊娠期肝内胆汁淤积症的危险因素分析. 临床和实验医学杂志. 2021(02): 200-203 . ![]() | |
6. | 段兴平,王燕,黄常友,郑会贤,罗一,覃正文,任郁. 妊娠期肝病的临床特征及研究进展. 临床肝胆病杂志. 2020(06): 1407-1411 . ![]() | |
7. | 陈韵洁,张晨,谭娟. 脂肪酸转运体蛋白FATP4、CD36、FABP1在妊娠期肝内胆汁淤积胎盘中表达研究. 中外医疗. 2020(15): 30-31+46 . ![]() | |
8. | 唐照青,俞海珍. 联合监护评估对妊娠期无症状高胆汁酸血症孕妇围生儿预后的价值. 中国现代药物应用. 2020(18): 19-22 . ![]() | |
9. | 汪学耀,张涛,荆成宝. 血清总胆汁酸与甘胆酸水平诊断妊娠期肝内胆汁淤积症能力的Meta分析. 现代检验医学杂志. 2020(05): 73-76 . ![]() | |
10. | 吕玉清. 我院中药处方中妊娠患者疾病及用药情况分析研究. 海峡药学. 2020(10): 176-178 . ![]() | |
11. | 刘燕,王丽娟,李盈盈. 综合护理在妊娠期肝内胆汁淤积症患者中的临床效果分析. 妇产与遗传(电子版). 2020(03): 40-44 . ![]() | |
12. | 张燕,王伟红. 妊娠期肝内胆汁淤积症孕妇血清总胆汁酸、谷草转氨酶及Th17/Treg平衡水平及临床意义. 中国计划生育学杂志. 2020(12): 2093-2097 . ![]() | |
13. | 马艳辉,邵久玲,王双梅. 低分子肝素治疗妊娠期肝内胆汁淤积症的疗效及对肝胆指标、母婴结局的影响. 哈尔滨医药. 2020(05): 438-440 . ![]() |